Abbott Laboratories (NYSE:ABT) Updates FY 2024 Earnings Guidance
Abbott Laboratories (NYSE:ABT – Get Free Report) updated its FY 2024 earnings guidance on Wednesday. The company provided EPS guidance of 4.640-4.700 for the period, compared to the consensus EPS estimate of 4.660. The company issued revenue guidance of -. Abbott Laboratories also updated its Q4 guidance to $1.31-1.37 EPS. Analyst Ratings Changes Several equities […]
More Stories
Westhaven Gold (CVE:WHN) Trading 5% Higher – What’s Next?
Westhaven Gold Corp. (CVE:WHN – Get Free Report)’s stock price was up 5% during trading on Tuesday . The stock...
Comptoir Group (LON:COM) Stock Price Down 4.5% – Time to Sell?
Comptoir Group PLC (LON:COM – Get Free Report)’s share price fell 4.5% during mid-day trading on Tuesday . The stock...
Zelira Therapeutics (OTCMKTS:ZLDAF) Trading 4.9% Higher – Here’s Why
Zelira Therapeutics Limited (OTCMKTS:ZLDAF – Get Free Report) shot up 4.9% on Tuesday . The stock traded as high as...
SK Growth Opportunities (SKGR) & Its Rivals Head-To-Head Contrast
Profitability This table compares SK Growth Opportunities and its rivals’ net margins, return on equity and return on assets. Net...
Stratus Properties (NASDAQ:STRS) Upgraded at StockNews.com
StockNews.com upgraded shares of Stratus Properties (NASDAQ:STRS – Free Report) from a sell rating to a hold rating in a...
Wedbush Issues Positive Outlook for Texas Roadhouse Earnings
Texas Roadhouse, Inc. (NASDAQ:TXRH – Free Report) – Equities research analysts at Wedbush raised their FY2024 earnings estimates for shares...